Trial Profile
PSMA Imaging of Localized Prostate Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs IAB 2M (Primary) ; Gallium (68Ga) gozetotide
- Indications Prostate cancer
- Focus Diagnostic use
- 18 Sep 2020 Status changed from active, no longer recruiting to completed.
- 29 Jun 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Sep 2019.
- 29 May 2019 Planned End Date changed from 1 Dec 2018 to 31 Dec 2019.